Rundle AG, Orjuela M, Mooney L, Tang D, Kim M, Calcagnotto A, Richie JP, Perera F
The clinical result is a medication that works through three complementary pathways simultaneously: Reduced appetite via GLP-1 and GIP receptor activation (eating less) Improved metabolic efficiency via GIP receptor activation on adipose tissue (storing fat less efficiently) Increased energy expenditure via glucagon receptor activation (burning more calories) This triple mechanism explains why retatrutides Phase 3 trial results exceed Mounjaros, which already uses two pathways
Your healthcare team will monitor for signs of dehydration or kidney problems if you experience significant vomiting or diarrhoea, and will watch for symptoms of gallbladder disease or pancreatitis
Fat loss typically accelerates noticeably
Here at Bella Sol Medical Spa, we dont gatekeep